InvestorsHub Logo
Followers 33
Posts 2911
Boards Moderated 1
Alias Born 10/24/2015

Re: None

Tuesday, 10/01/2019 6:24:15 PM

Tuesday, October 01, 2019 6:24:15 PM

Post# of 82
SITC title (P433) Initial results of the phase 1 portion of an ongoing phase 1/2 study of RP1 as a single agent and in combination with nivolumab in patients with solid tumors https://sitc.sitcancer.org/2019/abstracts/titles/index.php?filter=rp1
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent REPL News